What Is Breo Ellipta?
Breo Ellipta is a brand-name medication that comes in the form of an inhaler. It is specifically prescribed for adult patients who are dealing with breathing and lung problems, such as asthma and chronic obstructive pulmonary disease (COPD), which may include chronic bronchitis or emphysema. This medication is designed to be used once daily, providing long-term treatment for these respiratory conditions. It is a combination therapy that contains two active ingredients: fluticasone furoate, a corticosteroid, and vilanterol, a long-acting beta2-agonist bronchodilator. Fluticasone furoate works as an anti-inflammatory agent, reducing swelling and irritation in the airways. Vilanterol, on the other hand, functions as a bronchodilator, helping to relax and widen the air passages, making breathing easier for individuals with respiratory conditions. It's important to note that Breo Ellipta is not a rescue medication and should not be used for sudden and severe breathing difficulties. It is meant for daily maintenance therapy to provide ongoing relief and improvement in lung function. Patients should always follow their healthcare provider's instructions and seek medical advice if experiencing any concerning symptoms or side effects.
How to use Breo Ellipta?
To use Breo Ellipta properly, follow these steps: 1. Open the inhaler: Hold the inhaler in one hand, keeping the cover closed. Place your thumb in the thumb grip and push it away from you until the cover snaps fully open. You will hear a click sound. 2. Prepare the dose: Hold the inhaler in a level, flat position with the mouthpiece facing away from you. Slide the lever until you hear a click sound. This prepares the medicine for inhalation. 3. Breathe out: Exhale fully, away from the inhaler, ensuring that you do not breathe into the device. 4. Inhale the dose: Close your lips tightly around the mouthpiece, ensuring a good seal. Take a fast, deep breath through the inhaler, while keeping your head in an upright position. Remove the inhaler from your mouth and hold your breath for about 3-4 seconds to allow the medication to reach your lungs. 5. Exhale and clean: Breathe out slowly and gently away from the inhaler. Close the cover of the inhaler until you're ready to use it again. It's important to keep the inhaler clean and dry. Use a dry cloth or tissue to wipe the mouthpiece if necessary. Remember to use Breo Ellipta once daily as prescribed by your healthcare provider. Do not exceed the recommended dose, and always follow the instructions provided with the medication. If you have any questions or concerns, consult your doctor or pharmacist for clarification.
Breo Ellipta is an inhaled medication that combines two active ingredients, fluticasone furoate and vilanterol, to provide relief for breathing and lung problems such as asthma and chronic obstructive pulmonary disease (COPD). While effective, it is important to be aware of the following warnings associated with the use of Breo Ellipta: 1. Asthma-related death: Breo Ellipta is not indicated for the relief of acute symptoms or asthma attacks. It should not be used as a rescue inhaler. Patients should have a fast-acting inhalation medication readily available to treat sudden asthma symptoms or attacks. 2. Increased risk of asthma-related hospitalization: Using Breo Ellipta may increase the risk of asthma-related hospitalization, especially in patients with severe asthma. It is essential to monitor symptoms and adhere to a personalized asthma management plan. 3. Worsening of COPD: Breo Ellipta is not indicated for the treatment of acute exacerbations of COPD. If sudden breathing problems occur, patients should seek medical assistance immediately. 4. Pneumonia: In some cases, taking inhaled corticosteroids, one of the components of Breo Ellipta, may increase the risk of pneumonia, particularly in patients with COPD. Healthcare providers should monitor for signs and symptoms of pneumonia. 5. Growth effects in children: Breo Ellipta may have an impact on the growth of children. Pediatric patients using this medication should have their growth monitored regularly by a healthcare professional. As with any medication, it is crucial to discuss the potential risks and benefits of Breo Ellipta with a healthcare provider. It is also important to follow the prescribed dosage and usage instructions provided.
Before taking Breo Ellipta, it's important to consider certain warnings and precautions. Breo Ellipta is a brand-name inhaled medication that is typically prescribed to adult patients with breathing and lung problems like asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis or emphysema. Here are some key points to be aware of before using Breo Ellipta: 1. Allergic reactions: Individuals who are allergic to fluticasone furoate, vilanterol, or any other ingredients in Breo Ellipta should avoid using this medication. Signs of an allergic reaction may include swelling, rash, itching, or difficulty breathing. In such cases, immediate medical attention is necessary. 2. Increased risk of asthma-related death: Breo Ellipta is not approved for the treatment of asthma in individuals under 18 years old. Using Breo Ellipta in asthma patients may increase the risk of asthma-related death. 3. Worsening of existing conditions: Breo Ellipta may potentially worsen certain medical conditions, such as tuberculosis, infections, or untreated fungal, bacterial, or viral infections. It may also mask symptoms of these conditions. Before starting Breo Ellipta, it's crucial to inform your healthcare provider if you have any existing medical conditions. 4. Adrenal insufficiency: Long-term use of high-dose corticosteroids, including fluticasone furoate, one of the components of Breo Ellipta, may lead to adrenal insufficiency. This is a condition where the adrenal glands do not produce enough hormones. Symptoms may include fatigue, weakness, and decreased appetite. Regular monitoring with your healthcare provider is advised. 5. Increased risk of pneumonia: People with COPD who use inhaled corticosteroids, like fluticasone furoate, may have an increased risk of pneumonia. It's essential to discuss the benefits and risks with your healthcare provider. Always follow the instructions provided by your healthcare provider and read the medication guide for Breo Ellipta thoroughly before using the medication. If you have any concerns or questions, consult your healthcare provider for further guidance.
Common side effects of Breo Ellipta may include headache, throat irritation, cough, and upper respiratory tract infection. Some patients may also experience a fungal infection of the mouth or throat known as oral thrush. This can be minimized by rinsing the mouth after each use of the inhaler. In rare cases, Breo Ellipta may cause more serious side effects such as increased blood pressure, rapid heartbeat, chest pain, or worsening breathing problems. If you experience any of these symptoms, it is important to seek medical attention immediately. It is important to note that these are not all the possible side effects of Breo Ellipta. Different individuals may react differently to the medication. If you have any concerns or experience any unusual or severe side effects, it is essential to consult with your healthcare provider. They are best equipped to provide you with personalized advice and guidance based on your specific medical history and condition.
Breo Ellipta is a brand-name inhaled medication that contains a combination of two active ingredients: fluticasone furoate and vilanterol. Fluticasone furoate is a corticosteroid that helps to reduce inflammation in the airways. It works by decreasing the production of chemicals in the body that cause inflammation. By reducing inflammation, fluticasone furoate helps to prevent and control symptoms of asthma and COPD, such as wheezing, coughing, and shortness of breath. Vilanterol, on the other hand, is a long-acting beta-agonist (LABA) that helps to relax the muscles in the airways. By acting on specific receptors in the airways, vilanterol helps to open up the airways, making it easier to breathe. Both fluticasone furoate and vilanterol work together in Breo Ellipta to provide a dual-action treatment for breathing and lung problems. By addressing inflammation and muscle constriction, Breo Ellipta helps to improve lung function and control symptoms. It is important to note that Breo Ellipta is intended for use in adult patients only and should be used as prescribed by a healthcare professional.
Breo Ellipta, a brand-name inhaled medication, should be stored and handled properly to maintain its efficacy and safety. Here are the storage guidelines for Breo Ellipta: 1. Store at room temperature: Breo Ellipta should be stored at a room temperature ranging from 68°F to 77°F (20°C to 25°C). Avoid exposing it to extreme temperatures or direct sunlight. 2. Keep in the original packaging: The medication should be stored in its original packaging, with the inhaler device protected from moisture. Do not remove the inhaler from the tray until you are ready to use it. 3. Protect from moisture: Moisture can affect the performance of Breo Ellipta. It is essential to keep the inhaler dry at all times. Do not store it in the bathroom or any other area prone to high humidity. 4. Do not puncture or break: Do not puncture or break the inhaler device. This may lead to the loss of medication or improper dosing. 5. Keep out of reach of children: Store Breo Ellipta in a safe place, away from the reach of children and pets. Accidental exposure or ingestion can be dangerous. Remember, always follow the specific storage instructions provided by your healthcare provider or the medication packaging. If you have any doubts or concerns regarding storage, consult your healthcare professional for guidance.